+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neuropathic Pain"

Tapentadol Market - Global Forecast 2026-2032 - Product Thumbnail Image

Tapentadol Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 191 Pages
  • Global
From
Non-Opioid Pain Treatment Market Report 2025 - Product Thumbnail Image

Non-Opioid Pain Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Prescription Pain Medication Market Report 2025 - Product Thumbnail Image

Prescription Pain Medication Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Pain Management Global Market Report 2025 - Product Thumbnail Image

Pain Management Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Gabapentin Global Market Report 2025 - Product Thumbnail Image

Gabapentin Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Chronic Pain Treatment Global Market Report 2025 - Product Thumbnail Image

Chronic Pain Treatment Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
Chronic Pain Market Report 2025 - Product Thumbnail Image

Chronic Pain Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pregabalin Market - Global Strategic Business Report - Product Thumbnail Image

Pregabalin Market - Global Strategic Business Report

  • Report
  • February 2026
  • 372 Pages
  • Global
From
Neuropathic Pain Market - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain Market - Global Strategic Business Report

  • Report
  • February 2026
  • 386 Pages
  • Global
From
Oxycodone Hydrochloride Market - Global Strategic Business Report - Product Thumbnail Image

Oxycodone Hydrochloride Market - Global Strategic Business Report

  • Report
  • February 2026
  • 361 Pages
  • Global
From
From
Cancer Pain Management Market - Global Strategic Business Report - Product Thumbnail Image

Cancer Pain Management Market - Global Strategic Business Report

  • Report
  • February 2026
  • 588 Pages
  • Global
From
From
Gabapentin - Global Strategic Business Report - Product Thumbnail Image

Gabapentin - Global Strategic Business Report

  • Report
  • February 2026
  • 477 Pages
  • Global
From
Pain Management Drugs - Global Strategic Business Report - Product Thumbnail Image

Pain Management Drugs - Global Strategic Business Report

  • Report
  • February 2026
  • 326 Pages
  • Global
From
Non-opioid Pain Patch - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Patch - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • February 2026
  • 482 Pages
  • Global
From
Pain Management Devices Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pain Management Devices Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
Loading Indicator

Neuropathic pain is a type of chronic pain caused by damage to the nervous system. It is often described as a burning, tingling, or shooting sensation. Analgesics are medications used to reduce or eliminate pain. Neuropathic pain is often treated with a combination of analgesics, including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and anticonvulsants. Other treatments may include physical therapy, nerve blocks, and electrical stimulation. The neuropathic pain market is a rapidly growing segment of the analgesics market. It is driven by the increasing prevalence of chronic pain conditions, such as diabetes, cancer, and multiple sclerosis. The market is expected to benefit from the development of novel treatments, such as gene therapy and stem cell therapy. Some companies in the neuropathic pain market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Eli Lilly. Show Less Read more